imiquimod has been researched along with Kaposi Sarcoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, L; Dickson, MA; Gu, L; Kurtansky, N; Lezcano, C; Lin, E; Liu, S; Markova, A; Neumann, NM; Noor, S; Pulitzer, M; Rossi, A; Stoll, J; Yang, N | 1 |
| Can Kuru, B; Cinel, L; Ergun, T; Salman, A; Sarac, G; Yucelten, AD | 1 |
| Aragüés, M; De Arriba, AG; García-Diez, A; Goiriz, R; Ríos-Buceta, L | 1 |
| Echeverría-García, B; Guillén, C; Sanmartín, O | 1 |
| Alaibac, M; Bernardini, B; Calabró, L; Faggion, D; Oro, E | 1 |
| Becker, M; Fasel, JH; Kaya, G; Kostaki, M; Pham, XC; Piguet, V; Salomon, D; Stimec, BV; Toutous-Trellu, L | 1 |
| Griffin, TD; Jan, MM; Laskas, JW | 1 |
| Dummer, R; French, LE; Hofbauer, GF; Kempf, W; Prinz Vavricka, BM | 1 |
| Denham, I; Fairley, JL; Read, TR; Yoganathan, S | 1 |
| Beyeler, M; Burg, G; Dummer, R; Morcinek, J | 1 |
| Rosen, T | 1 |
| Babel, N; Bold, G; Eibl, N; Hammer, MH; Reinke, P; Rosenberger, C; Sefrin, A; Ulrich, C | 1 |
| Célestin Schartz, NE; Chevret, S; Kerob, D; Lebbé, C; Morel, P; Paz, C; Verola, O | 1 |
1 review(s) available for imiquimod and Kaposi Sarcoma
| Article | Year |
|---|---|
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors | 2003 |
1 trial(s) available for imiquimod and Kaposi Sarcoma
| Article | Year |
|---|---|
Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Drug-Related Side Effects and Adverse Reactions; Female; HIV Seronegativity; Humans; Imiquimod; Male; Middle Aged; Patient Compliance; Prospective Studies; Sarcoma, Kaposi; Skin Neoplasms | 2008 |
11 other study(ies) available for imiquimod and Kaposi Sarcoma
| Article | Year |
|---|---|
Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma.
Topics: Cryotherapy; Female; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Immunotherapy; Male; Middle Aged; Sarcoma, Kaposi; Sexual and Gender Minorities; Skin Neoplasms | 2023 |
Acquired progressive lymphangioma: Case report with partial response to imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Child, Preschool; Diagnosis, Differential; Female; Humans; Imiquimod; Lymphangioma; Sarcoma, Kaposi; Skin; Skin Neoplasms | 2017 |
Treatment of classic Kaposi's sarcoma with topical imiquimod.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Male; Sarcoma, Kaposi | 2009 |
[Clinical remission of classic Kaposi sarcoma with topical 5% imiquimod].
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Curettage; Electrocoagulation; Foot Diseases; Humans; Imiquimod; Male; Penile Neoplasms; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms | 2010 |
Imiquimod for the treatment of classical Kaposi's sarcoma.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Male; Ointments; Sarcoma, Kaposi; Skin Neoplasms; Toes; Treatment Outcome | 2010 |
Kaposi's sarcoma after repeated surgical procedures in an immunocompetent patient: the lymphatic hypothesis.
Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Dupuytren Contracture; Herpesvirus 8, Human; Humans; Imiquimod; Immunocompetence; Lymphatic System; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms; Treatment Outcome | 2010 |
Eruptive Kaposi sarcoma: an unusual presentation in an HIV-negative patient.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; CD4 Lymphocyte Count; Cryotherapy; Humans; Imiquimod; Italy; Lymphopenia; Male; Sarcoma, Kaposi; Skin Neoplasms | 2011 |
Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antigens, CD; Antineoplastic Agents; Female; Humans; Imiquimod; Immunohistochemistry; Kidney Transplantation; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms | 2012 |
Topical imiquimod 5% as a treatment for localized genital Kaposi's sarcoma in an HIV-negative man: a case report.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Male; Penis; Sarcoma, Kaposi | 2012 |
Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; HIV Infections; Humans; Imiquimod; Male; Sarcoma, Kaposi; Skin Neoplasms; Treatment Outcome | 2006 |
Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Graft Rejection; Herpesvirus 8, Human; Humans; Imiquimod; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Sarcoma, Kaposi; Sirolimus | 2008 |